Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from CBRS

Wedbush Gives a Thumbs Up to Cerebras Ahead of Its First Quarterly Earnings. What This Means for CBRS Stock Investors.

The firm maintained its "Outperform" rating on CBRS stock.

Barchart

A $550 Billion Reason to Buy Cerebras Stock

As Mizuho predicts a $550 billion market for fast AI inference by 2030, Wall Street is rightly excited about Cerebras stock.

Barchart

CBRS Stock Watch: Cerebras Soars as Analysts Issue 'Buy' Ratings

Wall Street analysts initiate bullish sentiment on Cerebras stock. Here’s why they believe CBRS shares will rip higher from here as the year unfolds.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Wedbush Thinks Cerebras Stock Is Ready for More Upside as CBRS Debuted at Just the Right Time

Fresh off one of the hottest IPOs in years, Cerebras is winning over Wall Street as Wedbush bets the AI upstart's best days are still ahead.

Barchart

Cerebras Stock Will Ride the AI Wave With Innovation-Driven Growth

Cathie Wood added to her position in Cerebras following its massive IPO.

Barchart

Cathie Wood Joins the Cerebras Bandwagon With More Than 100,000 Shares. Wait for It to Deliver Before You Buy In, Too.

Wood just added Cerebras, the latest hot AI name, to two of her Ark Invest funds.

Barchart

Cerebras Stock Staged an Explosive IPO. Investors Now Are Betting on 1.5% of Nvidia and AMD’s Combined Market Value for a Chance at Riches.

Cerebras Systems’ explosive IPO has pushed its valuation near the $100 billion threshold, driven entirely by a market vote of confidence in its revolutionary architecture rather than current financials.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Cerebras Just Rocketed Onto the Nasdaq. The Biggest IPO of 2026 Isn’t a Buy Here.

Cerebras offers a bold alternative to traditional AI chips, but CBRS stock’s explosive debut raises valuation concerns.

Barchart

Cerebras IPO Euphoria Sends CBRS Stock Into Rare Air

Cerebras Systems stock exploded after its IPO debut as investors rushed into the company's massive growth and $24.6 billion backlog story.

Barchart

Cerebras Is the Biggest IPO of the Year. If You Buy CBRS Stock Now, Brace Yourself for Volatility Ahead.

There's a lot of enthusiasm about this Nvidia competitor. What exactly is drawing investors?

Barchart

Cerebras Stock Pulls Back After Blockbuster IPO. Here's What's Next for the Potential Nvidia Rival.

Cerebras stock retreated as its blockbuster debut triggered massive profit-taking. But long-term investors should consider buying CBRS shares on this dip.

Barchart

Cisco Sends Nasdaq, S&P 500 to New Highs: Stock Market Today

Wall Street wasn't worried about an AI bubble on Thursday, with Cisco rallying on strong demand and Cerebras soaring in its market debut.

Kiplinger

The Cerebras IPO Is a Clear Sign That the Stock Market Is ‘Wafer Thin’

As a career investor, I am not buying into the Cerebras IPO hype.

Barchart

CBRS stock on Nasdaq: Cerebras makes U.S. Stock Market debut. Should you buy, invest in chipmaker shares?

Cerebras starts trading on Nasdaq Global Select Market on Thursday under the ticker symbol 'CBRS'.

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Dear Future Cerebras (CBRS) Stock Fans, Mark Your Calendars for May 14

Cerebras is nearing its debut with investor appetite surging and valuation estimates suddenly wearing much bigger shoes.

Kiplinger

Cerebras IPO: Should You Buy CBRS Stock?

The Cerebras IPO is one of the biggest offerings of the year so far, with the AI company making its market debut on Thursday, May 14.

Multichannel News

Charter Taps Nokia as Key 5G Tech Vendor for Spectrum Mobile

Charter is seeking to offload wireless traffic from its Verizon network lease using CBRS-based radio access network (RAN) infrastructure

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.